Maskin Scott

CEO Maskin Scott buys 554,712 shares (554.7K) of SUNE at $1.77; stock now $1.52, down 22.8% in 30 days from purchase

Scott's purchase of 554,712 shares at $1.77 represents a substantial commitment, expanding his holdings from 24 shares to 554,736 shares (554.7K) in a single transaction totaling $981,840.24. The stock has declined -22.8% over the 30 days since purchase, moving from the $1.77 transaction price to a current $1.52, placing it -52.0% below the 52-week high of $3.17. Scott's prior buy at SUNE on 2024-12-11 returned +15416.0% over 30 days, indicating his timing at that ticker has been exceptional; however, the current trade's post-purchase price action reflects a loss position, marking a departure from his established cross-ticker track record (100% win rate at 90-day mark, avg return +1414.5%). Against fundamentals, SUNE remains unprofitable (net income $-393.0K most recent quarter), though the company posted +26.5% annual revenue growth and trades at a $5.2M market cap on quarterly revenue of $19.0M.

Director Maskin Scott bought 3,500 shares of SUNE at $2.81 (12/11); holds 4,590 shares post-transaction (+321.1% vs prior holdings); 2 other insiders also bought within 14 days.

Director Maskin Scott purchased 3,500 shares at $2.81 on 2024-12-11, increasing his holdings from 1,090 to 4,590 shares (+321.1% increase). This purchase coincides with a cluster pattern: 2 other insiders also bought within the past 14 days. The company is unprofitable (net income of $-3,298,609.00 for the latest full fiscal year) despite strong revenue growth of +189.3% year-over-year, which presents a growth-but-unprofitable profile typical of early-stage companies. SUNE itself is recently listed (17 trading days), so traditional valuation and momentum benchmarks do not yet apply. The coordinated buying by multiple directors may reflect confidence in the pre-revenue-to-profitability transition or opportunistic entry post-IPO, but the company's negative earnings and early public-market stage warrant caution.

Director Maskin Scott bought 15,000 shares of PEGY at $1.43 on 2024-06-13, raising stake 37.9%; 3 other insiders also bought within 14 days

Maskin Scott, a Director, purchased 15,000 shares at $1.43, increasing his holdings from 39,544 to 54,544 shares—a 37.9% increase in position size. This transaction is part of a broader cluster pattern: 3 other insiders also bought within the past 14 days. The stock is currently trading at $65.00, representing a recovery of +30.7% over the past 90 days from the purchase price, though it remains -94.0% below its 52-week high of $1087.50. The company achieved +189.3% revenue growth (FY vs prior FY) and generated $1.2M in net income in the latest quarter, but remains unprofitable on a full-year basis. Multiple insider purchases at substantially lower price points, combined with recent revenue acceleration, merit attention to whether recovery thesis is taking hold among the company's leadership.